NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction

PHASE3CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2009

Conditions
Opiate Addiction
Interventions
DRUG

Methadone

The dose of the drug will be determined by a physician. The oral drug will be administered 1 dose per days, 7 days per week.

DRUG

Diamorphine hydrochloride

The dose of the drug will be determined by a physician. The injected drug will be administered up to 3 doses per day, 7 days per week.

Trial Locations (2)

Unknown

University of British Columbia Faculty of Medicine, Vancouver

University of Montreal, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of British Columbia

OTHER

NCT00175357 - NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction | Biotech Hunter | Biotech Hunter